Mavatar, the Swedish biotech company pioneering AI- and data-driven precision medicine, today announced the full global commercial launch of Mavatar Discovery, its next-generation platform that enables researchers to analyze complex biological data and uncover disease insights in hours instead of months.
Following a successful early release, Mavatar Discovery is now available worldwide - marking a major step toward making high-resolution, data-driven discovery accessible to research teams everywhere.
“The global launch of Mavatar Discovery signals a new era for biomedical research,” says Johan Juhlin, CEO and Co-Founder of Mavatar.
“Scientists no longer need to spend months cleaning datasets or building complex pipelines. With Mavatar Discovery, they can explore disease mechanisms, identify biomarkers, and generate pilot data in minutes - all without writing a single line of code.”
A New Starting Point for Research
Mavatar Discovery is powered by the company’s proprietary Deep Integrated Network Analysis (DINA) framework – a 100% data-driven engine built on more than two decades of scientific innovation from Linköping University and Karolinska Institutet in Sweden.
Unlike traditional bioinformatics tools that require extensive preprocessing, Mavatar Discovery provides ready-to-use, biologically meaningful networks created from thousands of public, peer-reviewed transcriptomic datasets.
Researchers can immediately:
· Visualize disease- and tissue-specific co-expression networks
· Compare two biological contexts at once to find shared or distinct patterns
· Explore functional annotations with full traceability back to original datasets
· Assess biomarkers and targets using tissue-specific expression charts
· Access Network Derived Signatures (NDS) - data-driven gene signature lists available only in Mavatar Discovery
· Dive deeper with classical enrichment analysis, unsupervised clustering, heatmaps, UMAPs, and more..
“Speed, simplicity, and intelligence were once competing priorities in bioinformatics,” says Juhlin. “Mavatar Discovery delivers all three.”
Free Trial & Global Open Webinar - November 26
To mark the global launch, Mavatar will host an open webinar: “The Most Exciting 30 Minutes in Biomedical Research This November.” Hosted by Camila Guerrero, PhD, the session will show how to:
· Build disease-specific co-expression networks in minutes
· Identify biomarkers using curated public datasets
· Strengthen grant applications with data-driven hypotheses
· Generate rapid pilot data for new projects
· Q&A session
All attendees will receive: A free trial of Mavatar Discovery and a workflow tutorial to continue exploring the platform.
